A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer
帕博利珠单抗联合紫杉醇或固定剂量卡培他滨治疗一线/二线转移性三阴性乳腺癌的 Ib 期临床试验
期刊:NPJ Breast Cancer
影响因子:6.5
doi:10.1038/s41523-023-00541-2
David B Page, Joanna Pucilowska, Brie Chun, Isaac Kim, Katherine Sanchez, Nicole Moxon, Staci Mellinger, Yaping Wu, Yoshinobu Koguchi, Valerie Conrad, William L Redmond, Maritza Martel, Zhaoyu Sun, Mary B Campbell, Alison Conlin, Anupama Acheson, Reva Basho, Philomena McAndrew, Mary El-Masry, Doroth
